Bristol-Myers Squibb Company
Aminoimidazopyridazines as kinase inhibitors

Abstract:

Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, (I) are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein. ##STR00001##